BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 3, 2001
View Archived Issues
Study questions cardiovascular safety of COX-2 inhibitors
Read More
Dimethaid highlights Pennsaid progress during fiscal 2001
Read More
Clinical programs at NPS continue steady progression during Q2
Read More
Devacade shown to enhance pain relief in phase II clinical trial
Read More
Phase I trial of Herzyme commences in breast and ovarian cancer
Read More
Tostrelle shows promise as treatment for female sexual dysfunction
Read More
Oxagen and Cerylid initiate gene discovery program for endometriosis
Read More
Motorola Life Sciences and SNP Consortium announce key alliance
Read More
Northfield seeks FDA approval of PolyHeme blood substitute
Read More
FDA accepts Orphan Medical's proposed response plan regarding Xyrem NDA
Read More
Antisoma takes on development of promising vascular targeting agent from the CRC
Read More
GW-432042: a potent and selective iNOS inhibitor debuts at ACS meeting
Read More
Collaborative investigations by Pfizer and Neurogen yield pyrazolopyrimidine NPY antagonists
Read More
Potent and selective CCR2B receptor antagonist described by GlaxoSmithKline
Read More
Novel adenosine kinase inhibitors with improved half-life and oral bioavailability
Read More
Nippon Kayaku withdraws central muscle relaxant from approval process
Read More
KW-4490 advances to clinical trials as potential antiasthmatic
Read More
Potential new antidepressants described at ACS meeting: AMPA receptor potentiators
Read More
Neuromuscular blockade reversed by cyclodextrin-based compounds
Read More
Anti-factor D MAb from Tanox reduces systemic inflammatory response in cardiopulmonary bypass model
Read More
Add-on therapy with CHF-1035 associated with improvement in clinical indicators of heart failure
Read More
Two recent patents cover P2X7 receptor antagonists and their potential uses
Read More
HMR-1556 selectively blocks slow delayed rectifier potassium channel in cardiac myocytes
Read More
JT describes new agents for hepatitis C
Read More
Sanofi-Synthelabo claims new series of beta3-adrenoceptor agonists
Read More
Safe and effective glucose-lowering agents prepared at Kyowa Hakko
Read More
Dipeptide HIV protease inhibitors in development at Japan Energy
Read More
Eisai describes new neovascularization inhibitors in patent literature
Read More